Tyrosine kinase inhibitor dose reduction during the management of accelerated phase chronic myeloid leukemia LEUKEMIA RES
3138 – HIGH CHROMOSOME INSTABILITY ACROSS ANEUPLOID SUBTYPES OF CHILDHOOD B-CELL ALL AND POTENTIAL ASSOCIATION WITH DISEASE PROGRESSION IN PDX MODELS. EXP HEMATOL
Vitamin C enhances NF-κB-driven epigenomic reprogramming and boosts the immunogenic properties of dendritic cells Nucleic Acids Res
DNA methylome combined with chromosome cluster-oriented analysis provides an early signature for cutaneous melanoma aggressiveness ELIFE
Methylome and transcriptome profiling of giant cell arteritis monocytes reveals novel pathways involved in disease pathogenesis and molecular response to glucocorticoids ANN RHEUM DIS
The trophectoderm acts as a niche for the inner cell mass through C/EBPα-regulated IL-6 signaling STEM CELL REP
Relevance of infections on the outcomes of patients with myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia treated with hypomethylating agents: a cohort study from the GESMD Ther Adv Hematol
Acute lymphoblastic leukemia necessitates GSH-dependent ferroptosis defenses to overcome FSP1-epigenetic silencing Redox Biol
Generation and proof-of-concept for allogeneic CD123 CAR-Delta One T (DOT) cells in acute myeloid leukemia J IMMUNOTHER CANCER